Optimizing cancer genome sequencing and analysis.
暂无分享,去创建一个
Obi L. Griffith | Li Ding | Malachi Griffith | Kilannin Krysiak | Joshua F. McMichael | Lee Trani | Avinash Ramu | David E. Larson | Elaine R. Mardis | Christopher A. Miller | Michael C. Wendl | Timothy J. Ley | Ha X. Dang | Christopher A. Maher | Shashikant Kulkarni | Zachary L. Skidmore | Amy Ly | Vincent Magrini | Ryan Demeter | R. Wilson | L. Trani | R. Fulton | E. Mardis | O. Griffith | L. Ding | D. Larson | M. Wendl | S. McGrath | T. Ley | M. Griffith | C. Maher | Jason R. Walker | V. Magrini | C. Fronick | J. Klco | S. Kulkarni | R. Demeter | M. Cordes | Kilannin Krysiak | Z. Skidmore | A. Ramu | H. Dang | Rachel E Austin | Amy Ly | Richard K. Wilson | Sean McGrath | Jason Walker | Robert S. Fulton | Matthew G. Cordes | Catrina C. Fronick | Rachel Austin | Jeffery M. Klco | Rachel Austin | R. Wilson | Ryan T. Demeter | Avinash Ramu
[1] Ravi Vijaya Satya,et al. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data , 2014, BMC Genomics.
[2] Eric W. Klee,et al. Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma , 2014, PLoS genetics.
[3] Elaine R. Mardis,et al. Applying next-generation sequencing to pancreatic cancer treatment , 2012, Nature Reviews Gastroenterology &Hepatology.
[4] Benjamin J. Raphael,et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. , 2013, The New England journal of medicine.
[5] Joshua F. McMichael,et al. Clonal evolution in relapsed acute myeloid leukemia revealed by whole genome sequencing , 2011, Nature.
[6] Jing Ma,et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia , 2015, Nature Communications.
[7] Roland Eils,et al. Coverage Bias and Sensitivity of Variant Calling for Four Whole-genome Sequencing Technologies , 2013, PloS one.
[8] Christopher A. Miller,et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. , 2014, Cancer cell.
[9] Euan A Ashley,et al. Performance comparison of whole-genome sequencing platforms , 2011, Nature Biotechnology.
[10] F. Markowetz,et al. Quantitative Image Analysis of Cellular Heterogeneity in Breast Tumors Complements Genomic Profiling , 2012, Science Translational Medicine.
[11] Lynda Chin,et al. Highly Recurrent TERT Promoter Mutations in Human Melanoma , 2013, Science.
[12] Stephen C. J. Parker,et al. Accurate and comprehensive sequencing of personal genomes. , 2011, Genome research.
[13] D. Schadendorf,et al. TERT Promoter Mutations in Familial and Sporadic Melanoma , 2013, Science.
[14] Obi L. Griffith,et al. Genome Modeling System: A Knowledge Management Platform for Genomics , 2015, PLoS Comput. Biol..
[15] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[16] Obi L. Griffith,et al. SciClone: Inferring Clonal Architecture and Tracking the Spatial and Temporal Patterns of Tumor Evolution , 2014, PLoS Comput. Biol..
[17] Peilin Jia,et al. Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers , 2013, Genome Medicine.
[18] A. Børresen-Dale,et al. The Life History of 21 Breast Cancers , 2012, Cell.
[19] Christopher A. Miller,et al. The Role of TP53 Mutations in the Origin and Evolution of Therapy-Related AML , 2014, Nature.
[20] Jan Albert,et al. PCR-Induced Transitions Are the Major Source of Error in Cleaned Ultra-Deep Pyrosequencing Data , 2013, PloS one.
[21] Joshua M. Stuart,et al. Global optimization of somatic variant identification in cancer genomes with a global community challenge , 2014, Nature Genetics.
[22] Lincoln D. Stein,et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes , 2012, Nature.